IRGD-targeted Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Delivery
Overview
Affiliations
Nanomedicine provides a promising platform for the molecular treatment of disease. An ongoing challenge in nanomedicine is the targeted delivery of intravenously administered nanoparticles to particular tissues, which is of special interest in cancer. In this study, we show that the conjugation of iRGD peptides, which specifically target tumor neovasculature, to the surface of Physalis mottle virus (PhMV)-like nanoparticles leads to rapid cellular uptake and tumor homing . We then show that iRGD-targeted PhMV loaded with the chemotherapeutic doxorubicin shows increased potency in a murine flank xenograft model of cancer. Our results validate that PhMV-like nanoparticles can be targeted to tumors through iRGD-peptide conjugation and suggest that iRGD-PhMV provides a promising platform for the targeted delivery of molecular cargo to tumors.
Advances in targeted therapy for tumor with nanocarriers: A review.
Cheng H, Liao J, Ma Y, Sarwar M, Yang H Mater Today Bio. 2025; 31:101583.
PMID: 40061211 PMC: 11889621. DOI: 10.1016/j.mtbio.2025.101583.
Plant-Derived Anti-Cancer Therapeutics and Biopharmaceuticals.
Hashim G, Shahgolzari M, Hefferon K, Yavari A, Venkataraman S Bioengineering (Basel). 2025; 12(1).
PMID: 39851281 PMC: 11759177. DOI: 10.3390/bioengineering12010007.
Plant Virus Nanoparticles Combat Cancer.
Shahgolzari M, Venkataraman S, Osano A, Akpa P, Hefferon K Vaccines (Basel). 2023; 11(8).
PMID: 37631846 PMC: 10459942. DOI: 10.3390/vaccines11081278.
Physalis Mottle Virus-Like Nanocarriers with Expanded Internal Loading Capacity.
Barkovich K, Wu Z, Zhao Z, Simms A, Chang E, Steinmetz N Bioconjug Chem. 2023; 34(9):1585-1595.
PMID: 37615599 PMC: 10538386. DOI: 10.1021/acs.bioconjchem.3c00269.